2096 Phase II trial of Irinotecan plus S-1 (IRIS) with Cetuximab (IRIS/Cet) in pre-treated patients with KRAS wild type of metastatic colorectal cancer (mCRC): HGCSG0902 updated analysis
Nakamura, M., Yuki, S., Nakatsumi, H., Muto, O., Hosokawa, A., Kato, T., Iwanaga, I., Hatanaka, K., Tsuji, Y., Sato, A., Eto, K., Furukawa, K., Okuda, H., Onodera, M., Fujikawa, K., Kudo, M., YokoyamaVolume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31018-8
Date:
September, 2015
File:
PDF, 60 KB
english, 2015